Maheshwari Anshul's Form 4/A amendment
AmendedSI-BONE, Inc. (SIBN) · filed Jul 22, 2025
- Accession no.
- 0001562180-25-005490
- Filed
- Jul 22, 2025
- Trade date
- Jul 2, 2025
- Filing delay
- 20 days
- Rule 10b5-1 plan
- Checked
- Original filed
- Jul 7, 2025
This filing lists 1 non-derivative transaction. It carries over 2 transactions from the original filing that it did not restate. Open-market sales total $75.7K. It was filed 20 days after the trade.
This amendment restates part of 0001562180-25-005342 (filed Jul 7, 2025). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maheshwari AnshulCIK 0001853089 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 2, 2025 | Common Stock | SSaleDisposed | −867 | $18.43 | −$15,978.81 | 217,906 | Direct |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001562180-25-005342 (filed Jul 7, 2025).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 2, 2025 | Common Stock | SSaleDisposed | −1,556 | $18.29F3 | −$28,459.24 | 218,773 | Direct | |
| Jul 2, 2025 | Common Stock | SSaleDisposed | −1,695 | $18.43 | −$31,238.85 | 217,078 | Direct |
Footnotes on the original
The footnotes that the prices of these transactions refer to on the original filing.
- F3
This transaction was executed in multiple trades at prices ranging from $18.12 USD to $18.40 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 13, 2024.
- F2
This Form 4/A is being filed to amend the prior Form 4 filed by the Reporting Person on July 7, 2025 to correct an administrative error that incorrectly overstated the number of shares of stock sold by 828 shares.
- F3
Includes 164,071 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.